Abbott closes OptiMedica buyout

August 19, 2013 by Brad Perriello

Abbott says it's closed the buyout of cataract laser surgery device maker OptiMedica that's worth up to $400 million.

Abbott closes OptiMedica buyout

Abbott (NYSE:ABT) said it closed the buyout of OptiMedica Corp. it announced in July, paying $250 million up front with another $150 million on the table if development, regulatory and sales milestones are met.

The buyout expands the Chicago-area healthcare giant's Abbott Medical Optics ophthalmology unit by adding femtosecond laser-assisted cataract surgery to its portfolio.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.